Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy

American Journal of Psychiatry

Volumn 162, Issue 4, 2005, Pages 667-675

  Modrego, Pedro J ^a   Fayed, Nicolás ^a   Pina, Miguel A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN REGION; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; EVALUATION; FEMALE; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL CORTEX; PARIETAL LOBE; PREDICTION; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; VERBAL BEHAVIOR;

AGED; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN; CHOLINE; COGNITION DISORDERS; COHORT STUDIES; CREATINE; FEMALE; FOLLOW-UP STUDIES; HIPPOCAMPUS; HUMANS; INOSITOL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OCCIPITAL LOBE; PROBABILITY; SEVERITY OF ILLNESS INDEX;

EID: 16844365618     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.4.667     Document Type: Article

References (42)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303-308; correction: 56: 760
2. Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, Albert MS: Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998; 50:1563-1571
3. McKelvey R, Bergman H, Stern J, Rush C, Zahirney G, Chertkow H: Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss. Can J Neurol Sci 1999; 26:23-28
4. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach J: Natural history of mild cognitive impairment in older persons. Neurology 2002; 59: 198-205
5. Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DG, Rapoport SI, Schapiro MB: Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 1998; 43:60-68
6. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L: Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58:397-405
7. Ritchie K, Touchon J: Mild cognitive impairment: conceptual basis and current nosological status. Lancet 2000; 355:225-228
8. Fazio F, Perani D, Gilardi MC, Colombo F, Cappa SF, Vallar G, Bettinardi V, Paulesu E, Alberoni M, Bressi S, Franceschi M, Lenzi GL: Metabolic impairment in human amnesia: a PET study of memory networks. J Cereb Blood Flow Metab 1992; 12:353-358
9. Golomb J, de León MJ, Kluger A, George AE, Tarshish C, Ferris SH: Hippocampal atrophy in normal aging, an association with recent memory impairment. Arch Neurol 1993; 50:967-973
10. Cortvit A, de León MJ, Golomb J, George AE, Tarshish CY, Bobinski M, Tsui W, De Santi S, Wegiel J, Wisniewski H: Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatr Q 1993; 64:371-387
11. Erkinjuntti T, Lee DH, Gao F, Steenhuis R, Eliasziw M, Fry R, Merskey H, Hachinski VC: Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol 1993; 50:305-310
12. Heun R, Mazanek M, Atzor KR, Tintera J, Gawehn J, Burkart M, Gänsicke M, Falkai P, Stoeter P: Amygdala-hippocampal atrophy and memory performance in dementia of Alzheimer type. Dement Geriatr Cogn Disord 1997; 8:329-336
13. Petersen RC, Jack CR Jr, Xu YC, Waring SC, O'Brien PC, Smith GE, Ivnik RJ, Tangalos EG, Boeve BF, Kokmen E: Memory and MRI-based hippocampal volumes in aging and AD. Neurology 2000; 54:581-587
14. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tangalos EG, Kokmen E: Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55:484-489
15. de León MJ, Golomb J, George AE, Convit A, Tarshish CY, McRae T, De Santi S, Smith G, Ferris SH, Noz M, Rusinek H: The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 1993; 14:897-906
16. Valenzuela MJ, Sachdev P: Magnetic resonance spectroscopy in AD. Neurology 2001; 56:592-598
17. Barker PB: N-Acetyl aspartate - a neuronal marker? (editorial). Ann Neurol 2001; 49:423-424
18. Ross BD: Biochemical considerations in 1H spectroscopy: glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed 1991; 4:59-63
19. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Kramer J, Jagust W, Miller B, Wolkowitz OM, Yaffe K, Weiner MW: Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 2002; 58:928-935
20. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO: In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch Gen Psychiatry 1999; 56:185-192
21. Block W, Jessen F, Traber F, Flacke S, Manka C, Lamerichs R, Keller E, Heun R, Schild H: Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. Arch Neurol 2002; 59:828-834
22. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD: Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 2002; 125: 2332-2341
23. Lobo A, Ezquerra J, Gómez Burgada F, Sala JM, Seva Díaz A: El Mini-Exxamen Cognoscitivo: un test sencillo y práctico para detectar alteraciones intelectuales en pacientes médicos. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1979; 7:189-202
24. González Torres M: Batería 144 para el estudio de las funciones mnésicas y de aprendizaje, in La exploración neuropsicológica. Edited by Peña Casanova J. Barcelona, Spain, MCR, 1988
25. Spreen O, Strauss E: Geriatric Depression Scale (GDS), in A Compendium of Neuropsychological Tests, 2nd ed. Edited by Spreen O, Strauss E. New York, Oxford University Press, 1998, pp 612-616
26. McKhann G, Drachmen D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
27. Tian J, Bucks RS, Haworth J, Wilcock G: Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatry 2003; 74:433-438
28. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW: Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001; 71:441-447
29. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52:1397-1403
30. Mega MS: The entorhinal cortex in Alzheimer's disease (editorial). J Neurol Neurosurg Psychiatry 2001; 71:431-432
31. Golomb J, de León MJ, Kluger A, George AE, Tarshish C, Ferris SH: Hippocampal atrophy in normal aging: an association with recent memory impairment. Arch Neurol 1993; 50:967-973
32. Blüml S: Data acquisition in the research mode, in Clinical MR Spectroscopy: Europrobe Training Course. Edited by Ross BD. Pasadena, Calif, Huntington Medical Research Institutes, 1996, pp 60-84
33. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC: Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 2001; 58:1395-1402
34. Price JL, Morris JC: Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999; 45: 358-368
35. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82:239-259
36. Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC: Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 2000; 55:210-217
37. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD: Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993; 187:433-437
38. Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD: Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995; 195:65-72
39. Rai GS, McConnell JR, Waldman A, Grant D, Chaudry M: Brain proton spectroscopy in dementia: an aid to clinical diagnosis (letter). Lancet 1999; 353:1063-1064
40. Coburn KL, Ashford JW, Moreno MA: Visual evoked potentials in dementia: selective delay of flash P2 in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1991; 3:431-435
41. Lewis DA, Campbell MJ, Terry RD, Morrison JH: Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 1987; 7:1799-1808
42. Kantarci K, Xu YC, Shiung MM, O'Brien PC, Cha RH, Smith GE, Ivnik RJ, Boeve BF, Edland SD, Kokmen E, Tangalos EG, Petersen RC, Jack CR Jr: Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 2002; 14:198-207